Physician profile
David H Ring
NPI 1497739056
$5,522.79
in general payments reported to CMS, 2019-2025
27 companies · $1,637 in 2025
The $1,637 reported for 2025 was more than what 89% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $157 · 2022: $702 · 2023: $1,135 · 2024: $1,063 · 2025: $1,637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,811 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,811.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $601.64 | 2022-2023 | |
| Inari Medical, INC. | $597.10 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Argon Medical Devices, INC. | $556.70 | 2019-2025 | Clot Management, Tips |
| Kerecis Limited | $397.75 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $347.18 | 2022-2025 | Cascadia Interbody System, Flowtriever |
| W. L. Gore & Associates, INC. | $332.45 | 2023-2025 | Gore Tag Conformable Thoracic Stent Graft, Gore Enform Preperitoneal Biomaterial, Gore Tag Thoracic Branch Endoprosthesis |
| Medical Device Business Services, INC. | $263.53 | 2019-2024 | |
| Pacira Pharmaceuticals Incorporated | $246.82 | 2020-2023 | Iovera |
| Penumbra, INC. | $234.92 | 2024-2025 | Indigo System, Ruby Coil |
| Atricure, INC. | $165.83 | 2024 | |
| Innovation Technologies INC | $163.80 | 2025 | Irrisept |
| Solventum Corporation | $153.29 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Cumberland Pharmaceuticals, INC. | $149.11 | 2023 | Caldolor |
| Medtronic, INC. | $126.60 | 2023-2025 | Kyphon Express II Kyphopak Tray, Abre, Concertotm |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $125.00 | 2019 | |
| Baxter Healthcare | $125.00 | 2019 | |
| Merck Sharp & Dohme LLC | $125.00 | 2019 | |
| Heron Therapeutics, INC. | $121.84 | 2025 | Aponvie, Zynrelef |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.17 | 2025 | |
| Terumo Medical Corporation | $114.31 | 2024 | Azur Cx Detachable |
| Medline Industries Lp | $99.82 | 2019 | |
| Kci USA, INC. | $98.61 | 2022 | |
| Boston Scientific Corporation | $55.67 | 2022-2023 | Sq-Rx Pulse Generator, Idc |
| Becton, Dickinson and Company | $34.50 | 2020 | |
| Medtronic Vascular, INC. | $32.40 | 2019 | |
| Bard Access Systems, INC. | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.